Vivaldi Biosciences
- Website
- vivaldibiosciences.com
- Total Funding
- $25.0M
- Last Round
- $23.0M Series AJan 2009
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Vivaldi Biosciences is a Biotech company. It has raised $25.0M in total across 2 rounds, most recently a $23.0M Series A round in Jan 2009. Investors include Bay City Capital, NGN Capital and Alexandria Venture Investments.
Funding History
Jan 2009
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Calico researches human aging using advanced technologies and model systems, applying that knowle...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vivaldi-biosciences"><img src="https://indexed.vc/api/badge/company/vivaldi-biosciences" alt="Vivaldi Biosciences on Indexed.vc" width="260" height="76" /></a>